[
	{
  		"assertions": [
    		166, 
    		167
  		], 
  		"citation": "Amin A, Lawson DH, Salama AK, et al. Phase II study of vemurafenib followed by ipilimumab in patients with previously untreated BRAF-mutated metastatic melanoma. J Immunother Cancer. 2016;4:44.", 
  		"doi": "10.1186/s40425-016-0148-7", 
  		"nct": "NCT01673854", 
  		"pmid": "27532019", 
  		"source_id": 66, 
  		"source_type": "Journal", 
  		"url": "https://doi.org/10.1186/s40425-016-0148-7"
	}
]